Please login to the form below

Not currently logged in
Email:
Password:

Ketchum loses healthcare head

Amanda Sefton leaves to pursue “passion project” in wine trade
Ketchum Amanda Sefton

The global head of the healthcare division of communications giant Ketchum has resigned.

Amanda Sefton is to leave later this month, after just over a year in the role. She has resigned to pursue 'a passion project' in the wine trade, Ketchum said.

Until a replacement is found, Ketchum's healthcare division will be run by Washington DC-based Lorraine Thelian, senior partner and vice chairman, supported by Greg Dauphin, marketing and integration manager on new business, the agency told PMLiVE.

“We're very sorry to see Amanda go but we're excited for her.  We wish Amanda all the best and would like to thank her for the contributions she has made to our global work,” the agency said in a statement

Meanwhile, six members of the UK healthcare practice are facing redundancy.

“We are consulting with six employees about a new staffing structure that better meets our client needs and is less top heavy,” said a Ketchum spokesperson.

 

10th December 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics